BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26023084)

  • 1. New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.
    Kisiel JB; Raimondo M; Taylor WR; Yab TC; Mahoney DW; Sun Z; Middha S; Baheti S; Zou H; Smyrk TC; Boardman LA; Petersen GM; Ahlquist DA
    Clin Cancer Res; 2015 Oct; 21(19):4473-81. PubMed ID: 26023084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age- and disease-related methylation of multiple genes in nonneoplastic duodenum and in duodenal juice.
    Matsubayashi H; Sato N; Brune K; Blackford AL; Hruban RH; Canto M; Yeo CJ; Goggins M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):573-83. PubMed ID: 15701843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates.
    Kisiel JB; Yab TC; Taylor WR; Chari ST; Petersen GM; Mahoney DW; Ahlquist DA
    Cancer; 2012 May; 118(10):2623-31. PubMed ID: 22083596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls.
    Majumder S; Raimondo M; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Devens ME; Mahoney DW; Smyrk TC; Pannala R; Chari ST; Vege SS; Topazian MD; Petersen BT; Levy MJ; Rajan E; Gleeson FC; Abu Dayyeh B; Nguyen CC; Faigel DO; Woodward TA; Wallace MB; Petersen G; Allawi HT; Lidgard GP; Kisiel JB; Ahlquist DA
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):676-683.e3. PubMed ID: 31323382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
    Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
    Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts.
    Kanda M; Knight S; Topazian M; Syngal S; Farrell J; Lee J; Kamel I; Lennon AM; Borges M; Young A; Fujiwara S; Seike J; Eshleman J; Hruban RH; Canto MI; Goggins M
    Gut; 2013 Jul; 62(7):1024-33. PubMed ID: 22859495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
    Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K
    Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
    Shinjo K; Hara K; Nagae G; Umeda T; Katsushima K; Suzuki M; Murofushi Y; Umezu Y; Takeuchi I; Takahashi S; Okuno Y; Matsuo K; Ito H; Tajima S; Aburatani H; Yamao K; Kondo Y
    PLoS One; 2020; 15(6):e0233782. PubMed ID: 32520974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms.
    Yu J; Sadakari Y; Shindo K; Suenaga M; Brant A; Almario JAN; Borges M; Barkley T; Fesharakizadeh S; Ford M; Hruban RH; Shin EJ; Lennon AM; Canto MI; Goggins M
    Gut; 2017 Sep; 66(9):1677-1687. PubMed ID: 27432539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.
    Matsubayashi H; Sato N; Fukushima N; Yeo CJ; Walter KM; Brune K; Sahin F; Hruban RH; Goggins M
    Clin Cancer Res; 2003 Apr; 9(4):1446-52. PubMed ID: 12684418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer.
    Park JW; Baek IH; Kim YT
    Scand J Surg; 2012; 101(1):38-44. PubMed ID: 22414467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.
    Fukushima N; Walter KM; Uek T; Sato N; Matsubayashi H; Cameron JL; Hruban RH; Canto M; Yeo CJ; Goggins M
    Cancer Biol Ther; 2003; 2(1):78-83. PubMed ID: 12673124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
    Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
    Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing DNA methylation patterns in pancreatic cancer genome.
    Tan AC; Jimeno A; Lin SH; Wheelhouse J; Chan F; Solomon A; Rajeshkumar NV; Rubio-Viqueira B; Hidalgo M
    Mol Oncol; 2009 Dec; 3(5-6):425-38. PubMed ID: 19497796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes.
    Thompson MJ; Rubbi L; Dawson DW; Donahue TR; Pellegrini M
    PLoS One; 2015; 10(6):e0128814. PubMed ID: 26039411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
    Wu JH; Liang XA; Wu YM; Li FS; Dai YM
    Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients undergoing pancreatoduodenectomy.
    Sanyal S; Siriwardena AK; Byers R
    Pancreatology; 2018 Jun; 18(4):458-462. PubMed ID: 29574096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.
    Eshleman JR; Norris AL; Sadakari Y; Debeljak M; Borges M; Harrington C; Lin E; Brant A; Barkley T; Almario JA; Topazian M; Farrell J; Syngal S; Lee JH; Yu J; Hruban RH; Kanda M; Canto MI; Goggins M
    Clin Gastroenterol Hepatol; 2015 May; 13(5):963-9.e4. PubMed ID: 25481712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.